Preparation of patient packages of VaxSyn,an experimental AIDS vaccine. Each pack contains the appropriate number of vaccine doses to treat a single patient for one year. VaxSyn is based on a genetically-engineered,recombinant form of the HIV protein gp160,which is a precursor to one of the outer surface proteins of the AIDS virus. VaxSyn contains no attenuated infectious parts of HIV & therefore carries no risk of transmitting AIDS. The vaccine is being developed by MicroGeneSys and is undergoing trials as a treatment of HIV-positive patients & as a potential vaccine against HIV infection | |
Licence : | Droits gérés |
Crédit: | Science Photo Library / Morgan, Hank |
Taille de l’image : | 3501 px × 5248 px |
Model Release : | Le droit n'est pas encore disponible. Merci de nous contacter avant utilisation. |
Property Release : | Non requis |
Restrictions : |
|